Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men and women between the ages of 40 and 85 (inclusive)
- People registered with the French Social Security system
- People who have a study partner available to complete several questionnaires or rating scales during the trial (travel costs will be covered by the trial organiser if either the participant or their study partner cannot drive)
- People who are fluent in French and able to read and write
Who may not be able to join:
- People for whom an MRI scan is not medically safe or suitable
- People with significant sensory problems (such as hearing or vision difficulties) that cannot be adequately corrected with aids or devices
- People whose dementia is caused by something other than a neurodegenerative disease, including those with a heavy burden of blood vessel-related risk factors, as judged by the investigator
- People who have another neurodegenerative condition, such as Lewy body dementia or Parkinson's disease
- People with another serious neurological condition, such as a brain tumour, stroke, epilepsy, or fluid build-up in the brain, or any other condition the investigator considers unsuitable for participation
- People with excessive alcohol intake or drug misuse, as judged by the investigator
- People who, in the investigator's opinion, may have difficulty following the trial procedures as required
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thibaud LEBOUVIER, MD, PhD, University Hospital, Lille
Phone: 3.20.44.60.21
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation coefficient between the mini Social cognition & Emotional Assessment - mini-SEA - total score and the Social Behavior Observer Checklist - SBOC - score in all participants.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.